Seres Therapeutics (MCRB) Shares Pop to Session Highs
- Nasdaq hits record; bank earnings validate Wall St. rally
- Intrawest Resorts (SNOW) Exploring a Possible Sale - Reuters
- Alibaba (BABA) Has No Plans to Acquire Rest of Groupon (GRPN) - Source
- Time (TIME) Said to Soon Begin Discussions with Interested Buyers - Bloomberg
- JPMorgan (JPM) Reports Q4 EPS of $1.71
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Seres Therapeutics (NASDAQ: MCRB) shares are popping to session highs. The stock is up around 2.2 percent Monday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Naked Brand Group, Inc. (NAKD) Enters $2M Common Stock Securities Purchase Agreement
- GameStop (GME) January puts active after reporting holiday Same-Store Sales results.
- Stocks with call price movement; BAC GDX
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!